Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
Vincent L, Gras L, Ceballos P, Finke J, Passweg J, Harel S, Rosinol L, Minnema M, Teipel R, van Doesum J, Hänel M, Lenain P, Botella-Garcia C, Koenecke C, Ducastelle S, Sanz J, Schroyens W, Zuckerman T, Monaco F, Koster L, de Wreede L, Hayden PJ, Schönland S, Yakoub-Agha I, Beksac M. Vincent L, et al. Among authors: ducastelle s. Bone Marrow Transplant. 2022 Mar;57(3):499-501. doi: 10.1038/s41409-021-01560-y. Epub 2022 Jan 10. Bone Marrow Transplant. 2022. PMID: 35013536 No abstract available.
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.
Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Michallet M. Detrait M, et al. Among authors: ducastelle s. Exp Hematol. 2012 Oct;40(10):792-9. doi: 10.1016/j.exphem.2012.06.003. Epub 2012 Jun 12. Exp Hematol. 2012. PMID: 22705505 Free article. Clinical Trial.
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.
Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I. Michallet M, et al. Among authors: ducastelle s. Cancer. 2013 Jan 1;119(1):107-14. doi: 10.1002/cncr.27686. Epub 2012 Jun 28. Cancer. 2013. PMID: 22744794 Free article.
Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.
Michallet M, Sobh M, Serrier C, Morisset S, Labussière H, Ducastelle S, Barraco F, Gilis L, Thomas X, Nicolini FE. Michallet M, et al. Among authors: ducastelle s. Leuk Lymphoma. 2015 Apr;56(4):999-1003. doi: 10.3109/10428194.2014.944518. Epub 2014 Aug 20. Leuk Lymphoma. 2015. PMID: 25029640
Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.
Michallet M, Bénet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini FE, Labussière H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle MC, Bienvenu AL, Persat F, De Monbrison F, Picot S, Vanhems P. Michallet M, et al. Among authors: ducastelle s. Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):991-7. doi: 10.1007/s10096-011-1397-5. Epub 2011 Sep 10. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21909650
Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
Dubois V, Detrait M, Sobh M, Morisset S, Labussière H, Giannoli C, Nicolini F, Moskovtchenko P, Mialou V, Ducastelle S, Rey S, Thomas X, Barraco F, Tedone N, Marry E, Garnier F, Bertrand Y, Michallet M. Dubois V, et al. Among authors: ducastelle s. Hum Immunol. 2016 Nov;77(11):1008-1015. doi: 10.1016/j.humimm.2016.02.004. Epub 2016 Feb 20. Hum Immunol. 2016. PMID: 26902994
Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
Collinge E, Loron S, Larcher MV, Elhamri M, Heiblig M, Deloire A, Ducastelle S, Labussière H, Barraco F, Wattel E, Salles G, Paubelle E, Thomas X. Collinge E, et al. Among authors: ducastelle s. Clin Lymphoma Myeloma Leuk. 2018 May;18(5):e211-e218. doi: 10.1016/j.clml.2018.02.018. Epub 2018 Mar 2. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29572159
Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.
Heiblig M, Elhamri M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Michallet M, Nicolini F, Plesa C, Wattel E, Salles G, Thomas X. Heiblig M, et al. Among authors: ducastelle s. Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016009. doi: 10.4084/MJHID.2016.009. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 26740870 Free PMC article.
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Heiblig M, Le Jeune C, Elhamri M, Balsat M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Nicolini F, Wattel E, Salles G, Thomas X. Heiblig M, et al. Among authors: ducastelle s. Leuk Lymphoma. 2017 Jan;58(1):110-117. doi: 10.1080/10428194.2016.1180688. Epub 2016 May 17. Leuk Lymphoma. 2017. PMID: 27184036
26 results